(Q45371467)

13 December 2017

title

Suppression of bladder cancer growth in mice by adeno-associated virus vector-mediated endostatin expression (English)

1 reference

13 December 2017

0 references

Jian Gang Pan

1

1 reference

13 December 2017

Xing Zhou

series ordinal

2

1 reference

13 December 2017

Ge Wa Zeng

series ordinal

3

1 reference

13 December 2017

Rui Fa Han

series ordinal

4

1 reference

13 December 2017

publication date

30 October 2010

1 reference

13 December 2017

1 reference

13 December 2017

volume

32

1 reference

13 December 2017

issue

2

1 reference

13 December 2017

page(s)

301-310

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-010-0122-9

13 December 2017

exact match

0 references

cites work

New approaches to treatment of metastatic bladder cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0122-9

Combination of adenovirus-mediated thymidine kinase gene therapy with cytotoxic chemotherapy in bladder cancer in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0122-9

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0122-9

Anti-angiogenic gene therapy of cancer: current status and future prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0122-9

Gene therapy delivery of endostatin enhances the treatment efficacy of radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0122-9

The effects of cetuximab alone and in combination with endostatin on vascular endothelial growth factor and interleukin-8 expression in human lung adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0122-9

AAV-mediated TRAIL gene expression driven by hTERT promoter suppressed human hepatocellular carcinoma growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0122-9

Adeno-associated virus 2-mediated antiangiogenic cancer gene therapy: long-term efficacy of a vector encoding angiostatin and endostatin over vectors encoding a single factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0122-9

Recombinant adeno-associated virus-mediated TRAIL gene therapy suppresses liver metastatic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0122-9

Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0122-9

Adeno-associated virus-mediated delivery of a mutant endostatin suppresses ovarian carcinoma growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0122-9

Adeno-associated virus vector-mediated systemic delivery of IFN-beta combined with low-dose cyclophosphamide affects tumor regression in murine neuroblastoma models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0122-9

An overview of current delivery systems in cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0122-9

Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0122-9

Continuous release of endostatin from microencapsulated engineered cells for tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0122-9

Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0122-9

Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0122-9

Adeno-associated virus serotypes: vector toolkit for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0122-9

Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin lymphoma

21 January 2018

1 reference

12 December 2020

[Chemotherapy of bladder carcinoma. Current status and trends]

1 reference

12 December 2020

Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

1 reference

12 December 2020

Adeno-associated virus and other potential vectors for angiostatin and endostatin gene therapy.

1 reference

12 December 2020

Toxicity and results of MVAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy in advanced urothelial carcinoma

1 reference

12 December 2020

Intravesical therapy for superficial bladder cancer

1 reference

12 December 2020

Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma

1 reference

12 December 2020

Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice.

1 reference

12 December 2020

The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing.

1 reference

12 December 2020

Adeno-associated virus-mediated delivery of antiangiogenic factors as an antitumor strategy.

1 reference

12 December 2020

Targeted integration of adeno-associated virus (AAV) into human chromosome 19

1 reference

12 December 2020

Intra-tumoral administration of naked plasmid DNA encoding mouse endostatin inhibits renal carcinoma growth

1 reference

12 December 2020

Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice.

1 reference

12 December 2020

10.1007/S13277-010-0122-9

Identifiers

DOI

1 reference

Dimensions Publication ID

13 December 2017

1005252414

0 references

1 reference